Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES
Status:
Unknown status
Trial end date:
2020-07-07
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of clopidogrel monotherapy versus aspirin plus P2Y12
antagonist following 3-month of DAPT in patients undergoing PCI with DES.